Dermitzakis, E.V.; Rikos, D.; Vikelis, M.; Xiromerisiou, G.; Zisopoulou, S.; Rallis, D.; Soldatos, P.; Vlachos, G.S.; Vasiliadis, G.G.; Argyriou, A.A.
Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study. Brain Sci. 2024, 14, 1169.
https://doi.org/10.3390/brainsci14121169
AMA Style
Dermitzakis EV, Rikos D, Vikelis M, Xiromerisiou G, Zisopoulou S, Rallis D, Soldatos P, Vlachos GS, Vasiliadis GG, Argyriou AA.
Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study. Brain Sciences. 2024; 14(12):1169.
https://doi.org/10.3390/brainsci14121169
Chicago/Turabian Style
Dermitzakis, Emmanouil V., Dimitrios Rikos, Michail Vikelis, Georgia Xiromerisiou, Styliani Zisopoulou, Dimitrios Rallis, Panagiotis Soldatos, George S. Vlachos, Georgios G. Vasiliadis, and Andreas A. Argyriou.
2024. "Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study" Brain Sciences 14, no. 12: 1169.
https://doi.org/10.3390/brainsci14121169
APA Style
Dermitzakis, E. V., Rikos, D., Vikelis, M., Xiromerisiou, G., Zisopoulou, S., Rallis, D., Soldatos, P., Vlachos, G. S., Vasiliadis, G. G., & Argyriou, A. A.
(2024). Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study. Brain Sciences, 14(12), 1169.
https://doi.org/10.3390/brainsci14121169